238 related articles for article (PubMed ID: 21501293)
1. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases.
Uede T
Pathol Int; 2011 May; 61(5):265-80. PubMed ID: 21501293
[TBL] [Abstract][Full Text] [Related]
2. α9β1 integrin-mediated signaling serves as an intrinsic regulator of pathogenic Th17 cell generation.
Kanayama M; Morimoto J; Matsui Y; Ikesue M; Danzaki K; Kurotaki D; Ito K; Yoshida T; Uede T
J Immunol; 2011 Dec; 187(11):5851-64. PubMed ID: 22039306
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology.
Buback F; Renkl AC; Schulz G; Weiss JM
Exp Dermatol; 2009 Sep; 18(9):750-9. PubMed ID: 19558497
[TBL] [Abstract][Full Text] [Related]
4. Tenascin-C aggravates autoimmune myocarditis via dendritic cell activation and Th17 cell differentiation.
Machino-Ohtsuka T; Tajiri K; Kimura T; Sakai S; Sato A; Yoshida T; Hiroe M; Yasutomi Y; Aonuma K; Imanaka-Yoshida K
J Am Heart Assoc; 2014 Nov; 3(6):e001052. PubMed ID: 25376187
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
Lee JL; Wang MJ; Sudhir PR; Chen GD; Chi CW; Chen JY
Cancer Res; 2007 Mar; 67(5):2089-97. PubMed ID: 17332338
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin; as a target molecule for the treatment of inflammatory diseases.
Morimoto J; Kon S; Matsui Y; Uede T
Curr Drug Targets; 2010 Apr; 11(4):494-505. PubMed ID: 20196720
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin and allergic disease: pathophysiology and implications for diagnostics and therapy.
Frenzel DF; Weiss JM
Expert Rev Clin Immunol; 2011 Jan; 7(1):93-109. PubMed ID: 21162653
[TBL] [Abstract][Full Text] [Related]
8. Syndecan-4 protects against osteopontin-mediated acute hepatic injury by masking functional domains of osteopontin.
Kon S; Ikesue M; Kimura C; Aoki M; Nakayama Y; Saito Y; Kurotaki D; Diao H; Matsui Y; Segawa T; Maeda M; Kojima T; Uede T
J Exp Med; 2008 Jan; 205(1):25-33. PubMed ID: 18158320
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of the integrin alpha9beta1 in bovine aortic valve interstitial cells.
Wiester LM; Giachelli CM
J Heart Valve Dis; 2003 Sep; 12(5):605-16. PubMed ID: 14565714
[TBL] [Abstract][Full Text] [Related]
10. A novel cryptic binding motif, LRSKSRSFQVSDEQY, in the C-terminal fragment of MMP-3/7-cleaved osteopontin as a novel ligand for α9β1 integrin is involved in the anti-type II collagen antibody-induced arthritis.
Kon S; Nakayama Y; Matsumoto N; Ito K; Kanayama M; Kimura C; Kouro H; Ashitomi D; Matsuda T; Uede T
PLoS One; 2014; 9(12):e116210. PubMed ID: 25545242
[TBL] [Abstract][Full Text] [Related]
11. IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production.
Jung MY; Son MH; Kim SH; Cho D; Kim TS
J Immunol; 2011 Jun; 186(12):6848-59. PubMed ID: 21551364
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin receptor-dependent regulation of Th1 and Th17 responses in autoimmune diseases: comment on the article by Chen et al.
Leng RX; Pan HF; Ye DQ
Arthritis Rheum; 2011 Feb; 63(2):568; author reply 568-9. PubMed ID: 21280012
[No Abstract] [Full Text] [Related]
13. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.
Chabas D; Baranzini SE; Mitchell D; Bernard CC; Rittling SR; Denhardt DT; Sobel RA; Lock C; Karpuj M; Pedotti R; Heller R; Oksenberg JR; Steinman L
Science; 2001 Nov; 294(5547):1731-5. PubMed ID: 11721059
[TBL] [Abstract][Full Text] [Related]
14. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells.
Lexberg MH; Taubner A; Albrecht I; Lepenies I; Richter A; Kamradt T; Radbruch A; Chang HD
Eur J Immunol; 2010 Nov; 40(11):3017-27. PubMed ID: 21061434
[TBL] [Abstract][Full Text] [Related]
16. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin.
Zhu B; Suzuki K; Goldberg HA; Rittling SR; Denhardt DT; McCulloch CA; Sodek J
J Cell Physiol; 2004 Jan; 198(1):155-67. PubMed ID: 14584055
[TBL] [Abstract][Full Text] [Related]
18. Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis.
Jacobs JP; Pettit AR; Shinohara ML; Jansson M; Cantor H; Gravallese EM; Mathis D; Benoist C
Arthritis Rheum; 2004 Aug; 50(8):2685-94. PubMed ID: 15334485
[TBL] [Abstract][Full Text] [Related]
19. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling.
Jones FS; Jones PL
Dev Dyn; 2000 Jun; 218(2):235-59. PubMed ID: 10842355
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin deficiency impacts the pancreatic TH1/TH2 cytokine profile following multiple low dose streptozotocin-induced diabetes.
Arafat HA; Lada E; Katakam AK; Amin N
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):555-62. PubMed ID: 17177137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
